The cardiovascular and haematopoietic systems have fundamental inter-relationships
during development, as well as in health and disease of the adult organism. Although …

The field of cell‐based transplantation has expanded considerably and is poised to become
an established cardiovascular therapy in the near future. In this review, we will focus on …

Increasing evidence suggests that circulating progenitor cells contribute to postnatal
neovascularization. These cells home to sites of ischemia, adopt an endothelial phenotype …

For over 10 years, bone marrow-derived endothelial progenitor cells (EPCs) have been
studied as a novel biomarker to assess the severity of cardiovascular diseases, and as a …

An increase in the number of circulating endothelial cells (CEC) and of bone marrow‐
derived endothelial progenitor cells (EPC) in the peripheral blood is associated with …

Cardiovascular disease is the leading cause of death and disability in the Western world. In
addition to the advancement of current therapeutic approaches to reduce the associated …

Since 1997, postnatal vasculogenesis has been purported to be an important mechanism for
neoangiogenesis via bone marrow (BM)-derived circulating endothelial progenitor cells …

Advanced knowledge in the field of stem cell biology and their ability to provide a cue for
counteracting several diseases are leading numerous researchers to focus their attention on …

Abstract Endothelial Progenitor Cells (EPC) are bone-marrow derived stem cells that are
postulated to contribute to postnatal vasculogenesis and to repair of damaged endothelium …

Cell-based therapy approaches for the restoration of blood flow in ischemic organs has
recently received growing interest. A considerable number of reports have documented the …